R

Repligen Corp.

RGEN Nasdaq Healthcare · Biological Products, (No Diagnostic Substances) Waltham, MA www.repligen.com/
$167.12
Mkt Cap 9.43B

Maker of equipment and materials used by biopharmaceutical manufacturers in the production of biologic drugs.

repligen.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$785.1M
15% CAGR
FCF TTM
$112.0M
14.3% margin
P/E RATIO
227.1x
—
P/FCF
84.2x
—
Running full 6-factor analysis…